ZCM
ASTH icon

Zebra Capital Management’s Astrana Health ASTH Stock Holding History

Zebra Capital Management’s Portfolio ASTH Stock Details ASTH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-6,194
Closed -$239K – 122
2022
Q2 		$239K Buy
6,194
+463
+8% +$17.6K 0.7% 61
2022
Q1 		$278K Buy
5,731
+138
+2% +$7.12K 0.64% 62
2021
Q4 		$411K Buy
5,593
+271
+5% +$22.3K 0.66% 51
2021
Q3 		$485K Hold
5,322
– – 0.59% 51
2021
Q2 		$334K Buy
+5,322
New +$197K 0.39% 98
2020
Q3 		– Sell
-18,356
Closed -$303K – 288
2020
Q2 		$303K Sell
18,356
-430
-2% -$6.77K 0.44% 88
2020
Q1 		$243K Buy
18,786
+2,894
+18% +$47.2K 0.39% 110
2019
Q4 		$293K Buy
+15,892
New +$264K 0.26% 166

Other funds holding ASTH

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
AWS
Atria Wealth Solutions New York $4.42B AUM 16.4% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
3C
325 Capital New York $274M AUM 49.96% 1-Year Est. Return

Zebra Capital Management's ASTH Position: Q3 2022 in Review

Zebra Capital Management sold out of Astrana Health (ASTH) in Q3 2022, closing a stake of 6,194 shares — an estimated $239K sold.

Zebra Capital Management first reported a position in ASTH in Q4 2019 and held it in 8 quarters. The position peaked at $485K in Q3 2021. 154 funds tracked by Wall St. Rank hold ASTH as of Q3 2022.

  • Zebra Capital Management reported no remaining Astrana Health position as of Q3 2022 after selling out during the quarter.
  • Zebra Capital Management sold 6,194 Astrana Health shares in Q3 2022, an estimated $239K.
  • Zebra Capital Management first reported a position in Astrana Health in Q4 2019 and held it in 8 quarters.
  • Zebra Capital Management's Astrana Health position peaked at $485K in Q3 2021.
  • 154 funds tracked by Wall St. Rank held Astrana Health as of Q3 2022.

Based on Zebra Capital Management's 13F filing for Q3 2022, filed 14 Nov 2022.